TY - JOUR
T1 - An exploratory study of sleep quality and quantity in children with causal variants in SYNGAP1, an autism risk gene
AU - Paasch, Valerie
AU - Doucoure, Aida
AU - Bifano, Morgan
AU - Smith-Hicks, Constance L.
N1 - Funding Information:
This work was supported by Bridge the Gap: SYNGAP1 Education and Research Foundation (CS–H) , Intellectual and Developmental Disabilities Research Center at Kennedy Krieger Institute ( P50 HD103538 ) (CS–H). AD was supported by the Centers for Disease Control and Prevention, Cooperative Agreement Number, NU50MN000004 . The funding sources had no role in the study design, collection, analysis, data interpretation or writing.
Publisher Copyright:
© 2023 The Authors
PY - 2023/7
Y1 - 2023/7
N2 - Study objectives: Sleep disturbances are reported in 62% of children with SYNGAP1-Intellectual Disability (SYNGAP1-ID), a rare neurodevelopmental disorder characterized by intellectual disability, epilepsy, autism spectrum disorder (ASD), sensory and behavioral challenges. Although Children's Sleep Habits Questionnaire (CSHQ) scores are elevated in children with SYNGAP1-ID factors that predict sleep disturbance are not well understood. The goal of this study is to identify predictors of sleep problems. Methods: Parents of 21 children with SYNGAP1-ID completed questionnaires, and 6 children wore the Actiwatch2 for 14 continuous days. Non-parametric analysis of psychometric scales and actigraphy data were performed. Actigraphy derived sleep parameters were compared to controls and rest activity rhythms were assessed using arctools an open-source R package. Results: CSHQ total sleep scores in children with SYNGAP1-ID and ASD were not different from children with SYNGAP1 without ASD (p = 0.61). Sleep anxiety (β 1.646, 95% CI 0.9566 to 2.336) and parasomnias (β 0.6294, 95% CI 0.06423 to 1.195) were strong predictors of bedtime resistance (R2 = 0.767, p < 0.001). The sedentary to active transition probability during the 12–18 h epoch (β = 0.004, p = 0.008, R2 = 0.85) and the duration of the active bout during the 18–24 h epoch (β = 0.166, p = 0.029, R2 = 0.74) were strong predictors of total sleep disturbance. Conclusion: The CSHQ may be a reliable measure of sleep difficulties in children with SYNGAP1-ID. Sleep anxiety, parasomnias and difficulty winding-down are significant contributors to sleep disturbances.
AB - Study objectives: Sleep disturbances are reported in 62% of children with SYNGAP1-Intellectual Disability (SYNGAP1-ID), a rare neurodevelopmental disorder characterized by intellectual disability, epilepsy, autism spectrum disorder (ASD), sensory and behavioral challenges. Although Children's Sleep Habits Questionnaire (CSHQ) scores are elevated in children with SYNGAP1-ID factors that predict sleep disturbance are not well understood. The goal of this study is to identify predictors of sleep problems. Methods: Parents of 21 children with SYNGAP1-ID completed questionnaires, and 6 children wore the Actiwatch2 for 14 continuous days. Non-parametric analysis of psychometric scales and actigraphy data were performed. Actigraphy derived sleep parameters were compared to controls and rest activity rhythms were assessed using arctools an open-source R package. Results: CSHQ total sleep scores in children with SYNGAP1-ID and ASD were not different from children with SYNGAP1 without ASD (p = 0.61). Sleep anxiety (β 1.646, 95% CI 0.9566 to 2.336) and parasomnias (β 0.6294, 95% CI 0.06423 to 1.195) were strong predictors of bedtime resistance (R2 = 0.767, p < 0.001). The sedentary to active transition probability during the 12–18 h epoch (β = 0.004, p = 0.008, R2 = 0.85) and the duration of the active bout during the 18–24 h epoch (β = 0.166, p = 0.029, R2 = 0.74) were strong predictors of total sleep disturbance. Conclusion: The CSHQ may be a reliable measure of sleep difficulties in children with SYNGAP1-ID. Sleep anxiety, parasomnias and difficulty winding-down are significant contributors to sleep disturbances.
KW - Actigraphy
KW - CSHQ
KW - SYNGAP1-ID
KW - Sleep problems
UR - http://www.scopus.com/inward/record.url?scp=85154053360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85154053360&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2023.04.008
DO - 10.1016/j.sleep.2023.04.008
M3 - Article
C2 - 37146502
AN - SCOPUS:85154053360
SN - 1389-9457
VL - 107
SP - 101
EP - 107
JO - Sleep Medicine
JF - Sleep Medicine
ER -